PP1

CAS No. 172889-26-8

PP1( AGL 1872 | EI 275 )

Catalog No. M12624 CAS No. 172889-26-8

PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 82 In Stock
2MG 46 In Stock
5MG 77 In Stock
10MG 115 In Stock
25MG 201 In Stock
50MG 276 In Stock
100MG 435 In Stock
200MG Get Quote In Stock
500MG 977 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PP1
  • Note
    Research use only, not for human use.
  • Brief Description
    PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
  • Description
    PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AGL 1872 | EI 275
  • Pathway
    Tyrosine Kinase
  • Target
    Bcr-Abl
  • Recptor
    Bcr-Abl| Kit| EGFR| Fyn| Lck
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    172889-26-8
  • Formula Weight
    281.36
  • Molecular Formula
    C16H19N5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:4 mg/mL (14.21 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    NC1=C2C(N(C(C)(C)C)N=C2C3=CC=C(C)C=C3)=NC=N1
  • Chemical Name
    1-(tert-butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hanke JH, et al. J Biol Chem, 1996, 271(2), 695-701.
molnova catalog
related products
  • Nocodazole

    Nocodazole is a rapidly-reversible inhibitor of microtubule polymerization, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 of 0.21 μM, 0.53 μM and 0.64 μM in cell-free assays, respectively.

  • L755507

    L755507 is an effective, selective agonist of β3-AR(IC50=35 nM).

  • Docetaxel

    Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung Y.